Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study
Titel:
Lenalidomide-dexamethasone versus observation in high-risk smoldering myeloma after 12 years of median follow-up time: A randomized, open-label study
Auteur:
Mateos, María-Victoria Hernández, Miguel-Teodoro Salvador, Carlos Rubia, Javier de la de Arriba, Felipe López-Corral, Lucía Rosiñol, Laura Paiva, Bruno Palomera, Luis Bargay, Joan Oriol, Albert Prosper, Felipe López, Javier Arguiñano, José-María Bladé, Joan Lahuerta, Juan-José San-Miguel, Jesús